Scholar Rock Holding Corporation
HealthcareNASDAQ:SRRK · NASDAQ Global Select
-$0.24 today
Vol 1.15M · Avg 1.45M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+36.15%
Period High
$51.51
Period Low
$27.92
Latest
$44.18
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Legend Biotech Corporation
NASDAQ:LEGN
$6.72B
Cidara Therapeutics, Inc.
CDTX
$5.61B
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
$4.12B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$3.91B
Beam Therapeutics Inc.
NASDAQ:BEAM
$2.99B
Adaptive Biotechnologies Corporation
NASDAQ:ADPT
$2.82B
Disc Medicine, Inc.
NASDAQ:IRON
$2.60B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.56B
Zai Lab Limited
NASDAQ:ZLAB
$1.92B
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
$1.57B
What is the latest SRRK filing?
The latest filing shown is 4 dated Jun 8, 2026.
How many recent filings does SRRK have?
Intrinsic Alpha currently shows 20 recent filings for SRRK.
Explore More
Continue the stock analysis
Jump to another research area for this company.